DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Shares Sold by Inceptionr LLC

Inceptionr LLC trimmed its holdings in DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) by 40.4% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 28,657 shares of the medical instruments supplier's stock after selling 19,387 shares during the quarter. Inceptionr LLC's holdings in DENTSPLY SIRONA were worth $544,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors also recently bought and sold shares of the company. FMR LLC increased its stake in shares of DENTSPLY SIRONA by 5.1% during the third quarter. FMR LLC now owns 9,056,774 shares of the medical instruments supplier's stock valued at $245,076,000 after purchasing an additional 436,031 shares in the last quarter. Pacer Advisors Inc. grew its stake in shares of DENTSPLY SIRONA by 15,105.1% in the 4th quarter. Pacer Advisors Inc. now owns 4,503,591 shares of the medical instruments supplier's stock worth $85,478,000 after buying an additional 4,473,972 shares during the last quarter. Bank of New York Mellon Corp increased its position in DENTSPLY SIRONA by 27.9% during the 4th quarter. Bank of New York Mellon Corp now owns 2,403,110 shares of the medical instruments supplier's stock valued at $45,611,000 after buying an additional 523,692 shares in the last quarter. Charles Schwab Investment Management Inc. raised its stake in DENTSPLY SIRONA by 1.7% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 2,101,133 shares of the medical instruments supplier's stock valued at $39,880,000 after buying an additional 35,360 shares during the last quarter. Finally, JPMorgan Chase & Co. boosted its holdings in DENTSPLY SIRONA by 206.3% in the third quarter. JPMorgan Chase & Co. now owns 1,847,389 shares of the medical instruments supplier's stock worth $49,990,000 after acquiring an additional 1,244,326 shares in the last quarter. 95.70% of the stock is owned by hedge funds and other institutional investors.

Remove Ads

Insider Buying and Selling at DENTSPLY SIRONA

In other DENTSPLY SIRONA news, Director Gregory T. Lucier bought 15,142 shares of the company's stock in a transaction that occurred on Monday, March 3rd. The shares were purchased at an average cost of $16.51 per share, for a total transaction of $249,994.42. Following the purchase, the director now directly owns 81,971 shares in the company, valued at $1,353,341.21. This represents a 22.66 % increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Insiders own 0.52% of the company's stock.

DENTSPLY SIRONA Stock Down 3.6 %

Shares of XRAY traded down $0.58 during mid-day trading on Wednesday, hitting $15.33. The company's stock had a trading volume of 2,938,152 shares, compared to its average volume of 2,584,298. The firm has a market capitalization of $3.05 billion, a price-to-earnings ratio of -7.41, a PEG ratio of 1.80 and a beta of 0.98. The company's 50-day moving average is $18.43 and its 200-day moving average is $21.01. The company has a current ratio of 1.25, a quick ratio of 0.84 and a debt-to-equity ratio of 0.72. DENTSPLY SIRONA Inc. has a 52-week low of $15.30 and a 52-week high of $34.28.

DENTSPLY SIRONA Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, April 11th. Stockholders of record on Friday, March 28th will be given a $0.16 dividend. This represents a $0.64 annualized dividend and a dividend yield of 4.17%. The ex-dividend date is Friday, March 28th. DENTSPLY SIRONA's payout ratio is -14.07%.

Wall Street Analyst Weigh In

Several equities analysts have recently issued reports on XRAY shares. Mizuho began coverage on DENTSPLY SIRONA in a research report on Wednesday, December 4th. They issued a "neutral" rating and a $21.00 price target for the company. Robert W. Baird decreased their target price on shares of DENTSPLY SIRONA from $22.00 to $20.00 and set a "neutral" rating for the company in a report on Friday, February 28th. Jefferies Financial Group cut shares of DENTSPLY SIRONA from a "buy" rating to a "hold" rating and cut their price target for the company from $30.00 to $20.00 in a report on Thursday, January 23rd. Morgan Stanley decreased their price objective on shares of DENTSPLY SIRONA from $30.00 to $23.00 and set an "overweight" rating for the company in a report on Tuesday, December 17th. Finally, Needham & Company LLC reduced their target price on DENTSPLY SIRONA from $25.00 to $23.00 and set a "buy" rating for the company in a report on Friday, February 28th. Eleven research analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. Based on data from MarketBeat, the company has an average rating of "Hold" and a consensus target price of $23.58.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.